The month ahead: December’s upcoming events
ASH and SABCS approach.
Kivu and Menarini against the odds
New first-in-human trials include Kivu and Menarini projects acting on PKT7 and KIF18A.
Amgen goes pivotal with subcutaneous Blincyto
A new first-line maintenance phase 3 joins a relapsed pivotal phase 2 study.
Sutro goes back to work
The restructured biotech’s new lead project enters phase 1.
Pfizer speeds ahead with bispecific development
The company will imminently start its third pivotal trial of PF-08634404.
Genmab pushes rina-S into its third phase 3
The Rainfol-04 trial in platinum-sensitive ovarian cancer will start next year.
BeOne joins the Kat6 pack
BG-75202 features among several projects starting first-in-human trials.
Pfizer moves into the VEGF bispecific fast lane
There will soon be three PD-(L)1 x VEGF projects in pivotal lung and colorectal cancer trials.
